Epsilon Healthcare Limited (HDRPF)
OTHER OTC:HDRPF
HDRPF Stock Chart & Stats
$0.01
>-$0.01(0.00%)
At close: 4:00 PM EST
$0.01
>-$0.01(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume8.00K
Average Volume (3M)N/A
Market Cap
$5.65M
Enterprise Value$22.09M
Total Cash (Recent Filing)$242.86K
Total Debt (Recent Filing)$14.16M
Price to Earnings (P/E)172.1
Beta0.11
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding389,104,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)4.19
Price to Sales (P/S)1.33
P/FCF Ratio-3.80
Enterprise Value/Market Cap3.91
Enterprise Value/Revenue2.35
Enterprise Value/Gross Profit205.95
Enterprise Value/Ebitda11.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound (2025)A ~53% revenue rebound in 2025 indicates recovering demand and improving product uptake across the medicinal cannabis portfolio. Sustained top-line growth provides the base for operating leverage, improved margins over time, and better contract negotiating power with distributors and partners.
CGMP Manufacturing & Private-label CapabilityOwning cGMP-compliant manufacturing and private-label capabilities is a durable operational advantage: it enables regulated pharma supply contracts, creates higher barriers to entry, and supports diversified revenue streams from contract manufacturing that can stabilize cash flow if volumes scale.
Positive Gross Profit (2025)Recording positive gross profit while overall losses persist suggests product-level economics are viable. If SG&A and overhead are controlled, this structural improvement allows margin expansion potential and a realistic pathway to operating profitability as sales scale and fixed costs are absorbed.
Bears Say
Persistent Net LossesSustained net losses (net margins around -22%) erode equity and constrain the company’s ability to self-fund growth. Continued unprofitability increases reliance on external financing, weakens negotiating leverage with suppliers, and makes long-term strategic investments riskier for stakeholders.
Negative Operating And Free Cash FlowConsistent negative operating and free cash flow indicate ongoing cash consumption from core operations. This structural cash burn increases liquidity risk, forces dependence on debt or equity raises, and limits the company’s capacity to invest in capacity, R&D, or commercial expansion without dilutive funding.
Material Increase In LeverageA jump to ~4.7x debt-to-equity reflects sharply reduced financial flexibility and higher refinancing and interest-rate risk. Elevated leverage constrains strategic options, raises default risk if cash flows falter, and can magnify losses for equity holders during adverse market or operational shocks.
Epsilon Healthcare Limited News
HDRPF FAQ
What was Epsilon Healthcare Limited’s price range in the past 12 months?
Epsilon Healthcare Limited lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Epsilon Healthcare Limited’s market cap?
Epsilon Healthcare Limited’s market cap is $5.65M.
When is Epsilon Healthcare Limited’s upcoming earnings report date?
Epsilon Healthcare Limited’s upcoming earnings report date is Sep 02, 2026 which is in 154 days.
How were Epsilon Healthcare Limited’s earnings last quarter?
Epsilon Healthcare Limited released its earnings results on Feb 27, 2026. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
Is Epsilon Healthcare Limited overvalued?
According to Wall Street analysts Epsilon Healthcare Limited’s price is currently Overvalued.
Does Epsilon Healthcare Limited pay dividends?
Epsilon Healthcare Limited does not currently pay dividends.
What is Epsilon Healthcare Limited’s EPS estimate?
Epsilon Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epsilon Healthcare Limited have?
Epsilon Healthcare Limited has 389,104,000 shares outstanding.
What happened to Epsilon Healthcare Limited’s price movement after its last earnings report?
Epsilon Healthcare Limited reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Epsilon Healthcare Limited?
Currently, no hedge funds are holding shares in HDRPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epsilon Healthcare Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth AU$30.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-74.34%
Trailing 12-Months
Asset Growth
84.04%
Trailing 12-Months
Company Description
Epsilon Healthcare Limited
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.
Technical Analysis
Vita Life Sciences Limited
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―